title: Rapacuronium: an alternative to succinylcholine for electroconvulsive therapy.
authors.affiliation: Department of Anesthesiology, Cedars Sinai Medical Center, Los Angeles, California, USA.
authors.forename: A G
authors.initials: AG
authors.lastname: Kadar
authors.forename: B A
authors.initials: BA
authors.lastname: Kramer
authors.forename: M C
authors.initials: MC
authors.lastname: Barth
authors.forename: P F
authors.initials: PF
authors.lastname: White
mesh_terms: D003866:Depressive Disorder / Q000628:therapy; D004198:Disease Susceptibility; D004565:Electroconvulsive Therapy; D006801:Humans; D008297:Male; D008305:Malignant Hyperthermia / Q000209:etiology / Q000517:prevention & control*; D008875:Middle Aged; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects*; D003473:Neuromuscular Nondepolarizing Agents; D013390:Succinylcholine / Q000009:adverse effects*; D014673:Vecuronium Bromide / Q000031:analogs & derivatives*
chemical_list: D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D014673:Vecuronium Bromide; C082938:rapacuronium; D013390:Succinylcholine